|
WO2020166181A1
|
|
Information processing device
|
|
JP2020061164A
|
|
Information processing system
|
|
JP2020058714A
|
|
Showcase
|
|
JP2020061044A
|
|
Information processing system
|
|
JP2018085094A
|
|
Information processing system
|
|
JP2017157216A
|
|
Information processing system
|
|
JP2018088161A
|
|
Information processing system and information processing method
|
|
JP2018085068A
|
|
Information processing system
|
|
JP2017220202A
|
|
Information processing system, information processing method, and program
|
|
JP2017220198A
|
|
Information processing system
|
|
JP2018045539A
|
|
Apparatus, method and program for predicting genetic risk to skin condition
|
|
JP2016067323A
|
|
Method for determining efficacy of diabetic medicine, determination apparatus, program and recording medium
|
|
JP2016057813A
|
|
Commodity management system and commodity management method
|
|
JP2015080464A
|
|
Method for determining dosage of diabetic medicine, determining device, program and recording medium
|
|
JP2012226660A
|
|
Sales management device and sales management method
|
|
JP2011010618A
|
|
Method for determining affection risk of arteriosclerotic disease of diabetic patient and test agent therefor
|
|
JP2011125218A
|
|
Method for anticipating sensitivity to phenylalanine derivative-based compound in diabetes patient
|
|
JP2009186425A
|
|
Evolution suppression of arteriosclerosis by pioglitazone or its salt, or sideration suppression of cardiovascular event
|
|
JP2008191716A
|
|
Method for presenting risk of disease and its program
|
|
WO2006126618A1
|
|
Method of determining gene polymorphism for judgment of disease risk level, method of judging disease risk level and array for relevant judgment
|
